Impact of Age on CD4 Response to Combination Antiretroviral Therapy: A Study in Tehran, Iran

Mehrdad Hasibi, Mahboubeh Hajiabdolbaghi, Shahin Hamzelou, Sara Sardashti, Maryam Foroughi, Zahra Bayat Jozani, SeyedAhmad SeyedAlinaghi

Department of Infectious Disease, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Iranian Research Center for HIV/AIDS (IRCHA), Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.

DOI: 10.4236/wja.2014.42020                

Abstract

Background: This study was undertaken to address the controversy regarding immunologic response to combination antiretroviral therapy (cART) among older patients. Methods: In a cross-sectional study all patients attending the HIV Clinic at Imam Khomeini Hospital (Tehran) from 2010 to 2011 were evaluated. Immunologic response was investigated using consecutive CD4+ T-cell counts in a one-year interval and outcomes were analyzed for older (>=50 yrs) and younger (<50 yrs) patients using SPSS version 16.0. Results: A total of 714 patients were actively enrolled in the clinic while 24 were 50 years or older, and had initiated ART; a similar random group of younger patients was selected as the control. Hepatitis C was the most prevalent co-infection in both groups. Patients with no serologic evidence of hepatitis B and C had significantly higher CD4+ T-cell counts than HIV/HBV co-infected patients after 12 months (p = 0.04). The average increased CD4+ T-cell counts in 6, 9, and 12 months of cART initiation were lower among older patients but the difference was not significant (50.75 vs. 123.08; p = 0.37, 132.87 vs. 710.58; p = 0.25, 271.27 vs. 500; p = 0.65). Conclusion: About 11% of the registered HIV-positive patients at our clinic were 50 years or older while their immunologic response to cART showed to be different. Specific needs of older HIV infected patients are highly recommended to be addressed in future treatment and care programs.

Keywords

HIV, Immunology, Age Groups

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Adekeye, O.A., Heiman, H.J., Onyeabor, O.S. and Hyacinth, H.I. (2012) The New Invincibles: HIV Screening among Older Adults in the US. PLoS One, 7, e43618. http://dx.doi.org/10.1371/journal.pone.0043618
[2]	(2011) Centers for Disease Control and Prevention; HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas. http://www.cdc.gov/hiv/pdf/statistics_2011_HIV_Surveillance_Report_vol_23.pdf
[3]	(2013) UNAIDS Report on the Global AIDS Epidemic. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNA IDS_Global_Report_2013_en.pdf
[4]	Greenbaum, A.H., Wilson, L.E., Keruly, J.C., Moore, R.D. and Gebo, K.A. (2008) Effect of Age and HAART Regimen on Clinical Response in an Urban Cohort of HIV-Infected Individuals. AIDS, 22, 2331-2339.
[5]	WHO (2009) Bulletin of the World Health Organization. http://www.who.int/bulletin/volumes/87/3/09-064030/en/
[6]	Nguyen, N. and Holodniy, M. (2008) HIV Infection in the Elderly. Clinical Interventions in Aging, 3, 453-472.
[7]	Iwuji, C.C., Churchill, D., Gilleece, Y., Weiss, H.A. and Fisher, M. (2013) Older HIV-Infected Individuals Present Late and Have a Higher Mortality: Brighton, UK Cohort Study. BMC Public Health, 13, 397.
[8]	UNAIDS (2013) Regional Report for the Middle East and North Africa (MENA).
[9]	Ministry of Health and Medical Education HIV/AIDS Statistics in Iran, Spring 2013.
[10]	Ministry of Health and Medical Education HIV/AIDS Statistics in Iran, Summer 2013.
[11]	Uccellini, L., Tseng, F.C., Monaco. A., Shebl, F.M., Pfeiffer, R., Dotrang, M., Buckett, D., Busch, M.P., Wang, E., Edlin, B.R., Marincola, F.M. and O’Brien, T.R. (2012) HCV RNA Levels in a Multiethnic Cohort of Injection Drug Users: Human Genetic, Viral and Demographic Associations. Hepatology, 56, 86-94. http://dx.doi.org/10.1002/hep.25652
[12]	Greig, J., Casas, E.C., O’Brien, D.P., Mills, E.J. and Ford, N. (2012) Association between Older Age and Adverse Outcomes on Antiretroviral Therapy: A Cohort Analysis of Programme Data from Nine Countries. AIDS, 26, S31-S37. http://dx.doi.org/10.1097/QAD.0b013e3283558446
[13]	Torres, T.S., Cardoso, S.W., de Souza V.L., Marins, L.M., Oliveira, M.S., Veloso, V.G. and Grinsztejn, B. (2013) Aging with HIV: An Overview of an Urban Cohort in Rio de Janeiro (Brazil) across Decades of Life. The Brazilian Journal of Infectious Diseases, 17, 324-331. http://dx.doi.org/10.1016/j.bjid.2012.10.024
[14]	Metallidis, S., Tsachouridou, O., Skoura, L., Zebekakis, P., Chrysanthidis, T., Pilalas, D., Bakaimi, I., Kollaras, P., Germanidis, G., Tsiara, A., Galanos, A., Malisiovas, N. and Nikolaidis, P. (2013) Older HIV-Infected Patients—An Underestimated Population in Northern Greece: Epidemiology, Risk of Disease Progression and Death. International Journal of Infectious Diseases, 17, e883-e891. http://dx.doi.org/10.1016/j.ijid.2013.02.023
[15]	Mutevedzi, P.C., Lessells, R.J., Rodger, A.J. and Newell, M.L. (2011) Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults. PLoS One, 6, e21795. http://dx.doi.org/10.1371/journal.pone.0021795
[16]	Cardoso, S.W., Torres, T.S., Santini-Oliveira, M., Marins, L.M., Veloso, V.G. and Grinsztejn, B. (2013) Aging with HIV: A Practical Review. The Brazilian Journal of Infectious Diseases, 17, 464-479. http://dx.doi.org/10.1016/j.bjid.2012.11.007
[17]	Grabar, S., Weiss, L. and Costagliola, D. (2006) HIV Infection in Older Patients in the HAART Era. Journal of Anti-microbial Chemotherapy, 57, 4-7. http://dx.doi.org/10.1093/jac/dki411